• View the talks
• 36 min
  1. Streptococcus pneumoniae: serotype diversity and epidemiology

  • Dr. Bambos Charalambous
• 38 min
  2. Tuberculosis: new treatments in evolution

  • Prof. Stephen Gillespie
• 55 min
  3. Current drugs for TB treatment

  • Dr. Kasha Singh
• 41 min
  4. Global progress in TB vaccine development

  • Prof. Helen McShane
• 34 min
  5. Management of MDR and XDR TB

  • Prof. Martin Boeree
• 61 min
  6. Non-tuberculous mycobacterial pulmonary disease (NTM-PD)

  • Prof. Jakko van Ingen
• 51 min
  7. The making of an influenza pandemic

  • Prof. Jonathan Van-Tam
• 51 min
  8. Responding to pandemic influenza

  • Prof. Jonathan Van-Tam
  • Dr. Chloe Sellwood
• 38 min
  9. Controlling pandemic flu

  • Prof. John Oxford
• 30 min
  10. The future of influenza vaccines

  • Dr. Marc P. Girard
• 29 min
  11. Emerging or newly discovered viral causes of acute lower respiratory tract infections worldwide

  • Dr. Marietjie Venter
  • Mrs. Orienka Hellferscee
• 34 min
  12. RSV vaccine development

  • Prof. Ruth Karron
• 32 min
  13. Respiratory mycoplasmas

  • Prof. Stephen Gillespie
• 52 min
  14. Infection in the cystic fibrosis lung

  • Dr. Stuart Elborn
• 34 min
  15. The role of infection at COPD exacerbations

  • Prof. Wisia Wedzicha
• 58 min
  16. An overview of non-cystic fibrosis bronchiectasis

  • Dr. Maeve P. Smith
• 27 min
  17. Legionella: epidemiology and human infection, environment and diagnosis

  • Dr. Diane Lindsay
• 24 min
  18. Pathogen discovery in the respiratory tract

  • Dr. H. Rogier van Doorn
• 38 min
  19. Aspergillosis infections and the lung

  • Prof. Rosemary Barnes
• 23 min
  20. Parasitic lung infections: protozoa, cestodes & trematodes

  • Dr. Vannan Kandi Vijayan
• 16 min
  21. Parasitic lung infections: nematodes

  • Dr. Vannan Kandi Vijayan
• 37 min
  22. Improving respiratory diagnostics (viruses)

  • Prof. David Murdoch

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. COPD exacerbations
3. Airway bacteria - stable COPD & exacerbations (1)
4. RCT of antibiotic therapy
5. Sputum characteristics
6. Bacterial eradication & inflammation
7. Changes in bacterial load
8. Risk of exacerbation & bacterial strain change
9. Strain change & bacterial load relationship
10. Lung microbiome in smoker vs. COPD (1)
11. Lung microbiome in smoker vs. COPD (2)
12. Respiratory viruses & exacerbation
13. Exacerbation recovery after onset
14. HRV and COPD exacerbations
15. Effect of common colds on IL6 in induced sputum
16. Plasma fibrinogen at exacerbation
17. Exacerbation frequency & common cold in COPD
18. Susceptibility of COPD patients to rhinovirus
19. Eosinophilic markers of viral exacerbations
20. Lower airway bacteria & rhinoviral infection
21. Sputum IL1B at bacterial exacerbations
22. Change in IP10 from baseline to exacerbation
23. IP10 ROC curve analysis
24. Airway bacteria - stable COPD & exacerbations (2)
25. Bacterial load & airway inflammation
26. Airway bacterial load & FEV1 decline
27. Lower lobe bronchiectasis - COPD & inflammation
28. Doxycycline vs. placebo (1)
29. Doxycycline vs. placebo (2)
30. Exacerbation frequency & bacterial colonization
31. Long term antibiotics
32. Patients with purulent/mucopurulent sputum
33. Macrolides - time to 1st exacerbation
34. Macrolides - sputum markers
35. Macrolide (Azithromycin) study
36. Macrolide study - subgroup analysis
37. RSV infection in stable COPD
38. Patterns of RSV infection
39. RSV & FEV1 decline
40. High sputum myeloperoxidase in COPD with RSV
41. Conclusion

Topics Covered

• Roles of viral and bacterial infections at exacerbations of COPD
• Airway bacteria
• RCT of antibiotic therapy
• Sputum characteristics
• Bacterial eradication & inflammation
• Bacterial strain change
• Lung microbiome in smoker vs. COPD
• Plasma fibrinogen at exacerbation
• Exacerbation frequency & common cold in COPD
• Rhinovirus
• Eosinophilic markers of viral exacerbations
• Lower lobe bronchiectasis
• Doxycycline vs. placebo
• Long term antibiotics
• Patients with purulent/mucopurulent sputum – Macrolide studies
• RSV infection in COPD

Links

Series:

• Respiratory Infection

Categories:

• Clinical Practice
• Microbiology

Therapeutic Areas:

• Infectious Diseases
• Respiratory Diseases

Talk Citation

Publication History

• Published on July 11, 2013

Financial Disclosures

• Prof. Wisia Wedzicha has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.